Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Andersson, Idun
DOB: 21-JUN-1990 (Age: 35)
Gender: female
Address:
Nygatan 198
252 20 Helsingborg (Sweden)
ID: 4023-994230-9 (ECI)
Report
Date: 17-DEC-2018
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Helsingborgs lasarett
254 37 Helsingborg (Sweden)
Specimen
Collected: 17-DEC-2018

Chemistry

Test 17-DEC-2018 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 158.3 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 116.6 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 71.2 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 63.8 H 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All lipid parameters are within or slightly above the normal range. HDL cholesterol is mildly elevated, which is generally considered protective. No evidence of dyslipidemia or increased cardiovascular risk from these results. No immediate laboratory concerns; continue routine monitoring and healthy lifestyle.